Company Filing History:
Years Active: 2015
Title: The Innovative Contributions of Audrey McConnell
Introduction
Audrey McConnell is a prominent inventor based in San Diego, California. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents. Her work focuses on humanized antibodies and their applications in treating diseases.
Latest Patents
Audrey McConnell holds a patent for "Humanized antibodies directed against complement protein C5." This invention relates to an isolated immunoglobulin heavy chain polypeptide and an isolated immunoglobulin light chain polypeptide that binds to complement protein C5. The invention provides a C5-binding agent that comprises the aforementioned immunoglobulin heavy chain polypeptide and immunoglobulin light chain polypeptide. Additionally, it offers an isolated complement protein C5 epitope, along with related vectors, compositions, and methods for using the C5-binding agent to treat C5-mediated diseases.
Career Highlights
Audrey is currently associated with Anaptysbio, Inc., where she continues to advance her research and development efforts. Her innovative work has positioned her as a key figure in the biotechnology sector, contributing to the understanding and treatment of complex diseases.
Collaborations
Throughout her career, Audrey has collaborated with notable professionals in her field, including Peter M. Bowers and David J. King. These collaborations have further enhanced her research and expanded the impact of her inventions.
Conclusion
Audrey McConnell's contributions to biotechnology through her innovative patents and collaborations highlight her role as a leading inventor in her field. Her work continues to pave the way for advancements in medical treatments and therapies.